Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis

Glucagon-like Peptide-1 receptor agonists (GLP1-ra) are a relatively new class of anti-hyperglycemic drugs which may positively affect bone metabolism and thereby decrease (osteoporotic) bone fracture risk. Data on the effect of GLP1-ra on fracture risk are scarce and limited to clinical trial data...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Calcif Tissue Int
Main Authors: Driessen, Johanna H. M., Henry, Ronald M. A., van Onzenoort, Hein A. W., Lalmohamed, Arief, Burden, Andrea M., Prieto-Alhambra, Daniel, Neef, Cees, Leufkens, Hubert G. M., de Vries, Frank
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4491344/
https://ncbi.nlm.nih.gov/pubmed/25894068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-015-9993-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados